Результаты поиска

Long-term projections of cancer prevalence in Australia to 2050: a population-based statistical modelling study.

BACKGROUND: Cancer prevalence is the number of people alive with a past cancer diagnosis in a specified number of previous years (e.g., last 5 or 30 years). This study estimates 1- to 30-year cancer prevalence in Australia for each year in 2025-2050, for 24 cancer types, the group of remaining cancers, and for all cancers combined. METHODS: We used validated methods to estimate prevalence as a function of incidence and survival, using tabulated data from the Australian Institute of Health and Welfare and incorporating the effect of influential cancer-specific factors. The number of people liv

Объединение медицинских услуг с предпочтением лечения: стимулирование правдивых самоотчетов.

ЦЕЛЬ: Самосообщенное соблюдение лекарств может зависеть от социально желательных ответов и неправдоподобной отчетности. Неправильная отчетность о поведении, связанном с присоединением, может привести к перекосам в оценках эффективности лечения (затратной). В ходе этого исследования были изучены пути обеспечения правдивого самосообщения в отношении лекарств и проведена оценка того, каким образом самосообщение (сопровождаемое правдой или регулярно сообщаемое) было связано с соблюдением и предпочтением лечения лекарств. МЕТОДЫ: Соблюдение лекарств было измерено после проведения эксперимента по ди

National survey of patient perspectives on cost discussions among recipients of copay assistance.

BackgroundIndividuals with cancer and other medical conditions often experience financial concerns from high costs-of-care and may utilize copay assistance programs (CAP). We sought to describe CAP recipients' experiences/preferences for cost discussions with clinicians.MethodsWe conducted a national, cross-sectional electronic-survey from 10/2022 to 11/2022 of CAP recipients with cancer or autoimmune conditions to assess patient perspectives on cost discussions. We used multivariable logistic regression models to explore associations of patient perspectives on cost discussions with patient ch

Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers.

OBJECTIVES: Patients with chronic haematological cancers are often treated on a relapsing-remitting pathway, which may extend for many years. Such diagnoses are associated with uncertainties that often cause anxiety and distress, meaning patients (and families) are susceptible to potentially prolonged emotional difficulties, across the cancer journey. Experiences and preferences regarding psychosocial needs and support over time are relatively unexplored, which this study aimed to address. SETTING AND DESIGN: Set within the UK's Haematological Malignancy Research Network (an ongoing populatio

Совпадение в полном тексте источника
… Macmillan centres were attended by some, as well as support days and events hosted by charities, such as Myeloma UK. Subtheme 1.2: knowing where to find support Most patients knew about online and face-to-face support groups, even if they did not want to use these resources. …

Living and dying with incurable cancer: a qualitative study on older patients' life values and healthcare professionals' responsivity.

BackgroundIn ageing Western societies, many older persons live with and die from cancer. Despite that present-day healthcare aims to be patient-centered, scientific literature has little knowledge to offer about how cancer and its treatment impact older persons' various outlooks on life and underlying life values. Therefore, the aims of this paper are to: 1) describe outlooks on life and life values of older people (≥ 70) living with incurable cancer; 2) elicit how healthcare professionals react and respond to these.MethodsSemi-structured qualitative interviews with 12 older persons with advan

Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review.

BackgroundA critical gap exits in understanding the dynamics of patient-based benefit-risk assessment (BRA) of medicines in chronic diseases during the disease journey.PurposeTo systematically review and synthesize current evidence on the changes of patients' preferences about the benefits and risks of medicines during their disease journey including the influence of disease duration and severity, and previous treatment experience.MethodsA systematic review of studies identified in PubMed and Embase, from inception to November 2020, was conducted in accordance with the PRISMA (Preferred Report

Wisely frugal: ensuring sustainable funding for novel cancer therapeutics through a budget impact analysis in resource-limited settings.

IntroductionCancer care in Sri Lanka is predominantly provided through its state health system which is free at the point of delivery. We performed a budget impact analysis of novel cancer drugs with a view to enabling better prioritising of their procurement.MethodsMedian survival gain was obtained for each indication of a novel cancer drug by a review of the literature. The direct cost of drug procurement was obtained from the Ministry of Health of Sri Lanka and the cost per life year gained was computed for each indication. Two thresholds - per capita gross domestic product (GDP) per life y

Measurement Properties of Patient-Reported Outcome Measures for Adolescent and Young Adult Survivors of a Central Nervous System Tumor: A Systematic Review.

Purpose: To identify and evaluate patient-reported outcome measures (PROMs) for assessing survivorship-related concepts for adolescent and young adult (AYA) survivors of central nervous system (CNS) tumors. Methods: We searched five electronic databases. Two researchers independently screened all titles for inclusion and used consensus-based standards for the selection of health measurement instruments (COSMIN) guidance to grade the quality of evidence for each measurement property. Results: Four studies met eligibility criteria: single-item pain thermometer; single-item fatigue thermometer; 3

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review.

The efficacy of SARS-CoV-2 vaccination in patients with hematological malignancies (HM) appears limited due to disease and treatment-associated immune impairment. We conducted a systematic review of prospective studies published from 10/12/2021 onwards in medical databases to assess clinical efficacy parameters, humoral and cellular immunogenicity and adverse events (AE) following two doses of COVID-19 approved vaccines. In 57 eligible studies reporting 7393 patients, clinical outcomes were rarely reported and rates of SARS-CoV-2 infection (range 0-11.9%), symptomatic disease (0-2.7%), hospita

Совпадение в полном тексте источника
… The majority of studies received funding from academic organizations, charities or foundations, or governmental institutions (29 of 57 studies). Eight studies received no dedicated funding, one study was funded by the pharmaceutical industry and the remaining did not disclose funding sources. …

Cardiac Amyloidosis Treatment.

Cardiac amyloidosis (CA) is a restrictive cardiomyopathy with a traditionally poor prognosis. Until recently, CA treatment options were limited and consisted predominantly of managing symptoms and disease-related complications. However, the last decade has seen significant advances in disease-modifying therapies, increased awareness of CA, and improved diagnostic methods resulting in earlier diagnoses. In this review, we provide an overview of current and experimental treatments for the predominant types of CA: transthyretin cardiac amyloidosis (ATTR-CA) and immunoglobulin light chain (AL)-med

Clinical Application of Chinese Herbal Injection for Cancer Care: Evidence-Mapping of the Systematic Reviews, Meta-analyses, and Randomized Controlled Trials.

Background and objective: Cancer is a life-threatening disease worldwide and current standard therapy cannot fulfill all clinical needs. Chinese herbal injections have been widely used for cancer in Chinese and Western hospitals in China. This study aimed to apply evidence mapping in order to provide an overview of the clinical application of Chinese herbal injections in cancer care based on randomized controlled trials, systematic reviews, and meta-analyses. Methods and results: Seven databases were systematically searched for eligible randomized controlled trials, systematic reviews, and met

Depoliticisation, Resilience and the Herceptin Post-Code Lottery Crisis: Holding Back the Tide.

Research Highlights and Abstract This article: Covers new empirical terrain in the study of depoliticisation, with an in-depth case study of health technology regulation;Analyses depoliticisation from a novel analytical perspective, examining how depoliticised institutions are resilient to external pressure for politicisation;Posits a distinctive framework for analysing resilience, drawing on cognate literatures on policy networks and agencification;Raises interesting and distinctive questions about the nature of depoliticisation in advanced liberal democracies, arguing it is more contested th

Совпадение в полном тексте источника
… Here, there was an intensification of pressure group activity, particularly from long-campaigning cancer charities such as Breakthrough Breast Cancer and Cancer Bacup ( Hind et al. 2011 , 24) but also a more temporary pressure group, Women Fighting for Herceptin (WFH). …

Rare diseases and orphan drugs: Latvian story.

BackgroundTen years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in the public health system, though there are significant differences in the national healthcare services for rare diseases among the EU States. This study aims to determine situation in the field of rare diseases in Latvia and compare it with other European countries.MethodsWe used the national plan for

Совпадение в полном тексте источника
… Research Generally funding is available for rare disease projects (through state budget, charities and pharmaceutical companies) [ 6 ] although these funds are not specifically designed for rare disease research. …

Urine 5-HIAA and quality of life in neuroendocrine neoplasia. Is there an association?

BACKGROUND: To determine whether urine 5-HIAA (u5HIAA) concentrations correlate with health-related quality of life (HRQL) in patients with neuroendocrine neoplasms (NEN). METHODS: A retrospective single-centre cross-sectional study was conducted including 386 patients with histological or radiological diagnosis of NEN. Patients completed standardized questionnaires at clinic appointments. Spot u5HIAA concentrations were correlated with Patient Health Questionnaire-9 (PHQ-9) depression scores, Generalized Anxiety Disorder-7 (GAD-7) anxiety scores, European Organisation for Research and Treatm

Совпадение в полном тексте источника
… Therefore, the need for psychosocial care is feasibly under-recognised despite extensive resources made available through patient advocacy groups and charities, such as Neuroendocrine Cancer UK. …

NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma.

Medulloblastoma (MB) is the most common malignant solid paediatric brain tumour. The standard treatment for MB is surgical resection of the tumour, radiation and chemotherapy. This therapy is associated with high morbidity and adverse side effects. Hence, more targeted and less toxic therapies are vitally needed to improve the quality of life of survivors. NPI-0052 is a novel proteasome inhibitor that irreversibly binds the 20S proteasome subunit. This compound has anti-tumour activity in metastatic solid tumours, glioblastoma and multiple myeloma with a good safety profile. Importantly, NPI-0

Сопоставление клинических результатов между пиелоперфюзелями и микроволновой абсорбацией почечных клеток.

Справочная информация: Сопоставимость характерна для пациентов с множественным склерозом (МС), что повышает сложность лечения заболеваний и экономического бремени и ухудшает их прогноз и качество жизни. Не хватает реальных данных, позволяющих сопоставлять коморбиды и модели множественной смертности, характерные для лиц, охваченных системой страхования на коммерческой основе, и лиц, охваченных системой " Medicare " . Цель: Оценка структуры коморбидности и многоженства среди пациентов с НР в американской компании " Компромисс " и " Медикэр аппетит " . Методы: Это ре

16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid antibodies. The 16th International Congress on Antiphospholipid Antibodies Task Force on APS Treatment Trends reviewed the current status with regard to existing and novel treatment trends for APS, which is the focus of this Task Force report. The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, antiplatelet agents, adjunctive ther

Что важнее всего для людей, живущих с эпилепсией? Быстрое рассмотрение качественных исследований, касающихся результатов в области здравоохранения.

В настоящее время результаты, измеряемые и сообщаемые в ходе клинических испытаний для взрослых с эпилепсией, являются разнородными и зачастую не отбирались в консультации с лицами, живущими с эпилепсией. В рамках более широкого проекта по разработке базового набора результатов клинических испытаний для взрослых с эпилепсией (проект ЭПСЕТ) был проведен быстрый обзор опубликованной качественной литературы. В целях выявления исследований, в которых обсуждаются мнения взрослых с эпилепсией и их представителей, был проведен поиск с использованием установленного качественного методологического филь

Совпадение в полном тексте источника
… ACKNOWLEDGMENTS The authors would like to thank the Association of British Neurologists and Guarantors of Brain charities, who funded researcher time to undertake this work, as part of a Clinical Research Training Fellowship grant (awarded to J.W.M.). …

Early Palliative Care in Acute Myeloid Leukemia.

BackgroundSeveral novel targeted therapies seem to improve the outcome of acute myeloid leukemia (AML) patients. Nonetheless, the 5-year survival rate remains below 40%, and the trajectory of the disease remains physically and emotionally challenging, with little time to make relevant decisions. For patients with advanced solid tumors, the integration of early palliative care (EPC) with standard oncologic care a few weeks after diagnosis has demonstrated several benefits. However, this model is underutilized in patients with hematologic malignancies.MethodsIn this article, we analyze the palli

Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers.

OBJECTIVES: Haematological malignancies are the fifth most common cancer in the UK, with chronic subtypes comprising around a third of all new diagnoses. These complex diseases have some similarities with other cancers, but often require different management. Surgical resection is not possible, and while some are curable with intensive chemotherapy, most indolent subtypes are managed with non-aggressive intermittent or continuous treatment, often over many years. Little is known about the views of patients with chronic haematological cancers regarding treatment decision making (TDM), a deficit

Совпадение в полном тексте источника
… This group also tended to access information from many sources, including UK charities (eg, Myeloma UK and CLL Support Association), national and local support groups, on-line patient forums (mainly US based), clinical nurse specialists and peer-reviewed articles. …